Intensity Therapeutics (INTS) Selling, General & Administrative (2022 - 2026)
Intensity Therapeutics' Selling, General & Administrative was $1.25 million in Q2 2026, up 7.5% from $1.16 million a year earlier but down 6.0% from the prior quarter.
Intensity Therapeutics (INTS) Selling, General & Administrative (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Intensity Therapeutics' Selling, General & Administrative was $5.4 million through Jun 30, 2026, up 7.5% year-over-year; for FY2025, it was $5.19 million, down 14.8% from FY2024.
- Selling, General & Administrative shows a three-year compound annual growth rate of 29.0% (FY2022 to FY2025).
- In earlier years, Selling, General & Administrative was $6.09 million in FY2024 (+72.3%), $3.53 million in FY2023 (+46.1%) and $2.42 million in FY2022.
- Quarterly Selling, General & Administrative has moved between $362,000 (Q2 2023) and $1.93 million (Q1 2024) over five years.
- Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with an average decline of 2.8% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q2 2024 (growth of 316.0%); the worst was Q1 2025 (a decline of 37.5%).
- Per Business Quant data, INTS's Selling, General & Administrative in the three quarters before Q2 2026 was $1.33 million (Q1 2026), $1.64 million (Q4 2025) and $1.18 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Intensity Therapeutics | 9.93 Mn | 9.93 Mn | - | 1.25 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 362,000.00 |
| Mar 31, 2023 | 480,000.00 |
| Dec 31, 2022 | 583,034.00 |
| Sep 30, 2022 | 607,113.00 |
| Jun 30, 2022 | 543,830.00 |
Intensity Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INTS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();